357
Views
2
CrossRef citations to date
0
Altmetric
Articles

Past-Year Ketamine Use: Evidence from a United States Population, 2015-2019

, PhD
Pages 134-140 | Received 11 Aug 2021, Accepted 25 Jan 2022, Published online: 29 Mar 2022

References

  • Bourne, A., D. Reid, F. Hickson, S. Torres Rueda, and P. Weatherburn. 2014. The Chemsex study: Drug use in sexual settings among gay & bisexual men in Lambeth, Southwark & lewisham. London: Sigma Research, London School of Hygiene & Tropical Medicine. www.sigmaresearch.org.uk/chemsex.
  • Bredlau, A. L., R. Thakur, D. N. Korones, and R. H. Dworkin. 2013. Ketamine for pain in adults and children with cancer: A systematic review and synthesis of the literature. Pain Medicine 14 (10):1505–17. doi:10.1111/pme.12182.
  • Center for Behavioral Health Statistics and Quality. 2017. “How to prepare and analyze pair data in the national survey on drug use and health.” In Substance abuse and mental health services administration, 1–32. Rockville, MD
  • Center for Behavioral Health Statistics and Quality. (2019). 2018 national survey on drug use and health: methodological resource book (Section 2, Sample Design Report). Substance Abuse and Mental Health Services Administration, Rockville, MD.
  • Correll, G. E., J. Maleki, E. J. Gracely, J. J. Muir, and R. E. Harbut.Pain Medicine2004. Subanesthetic ketamine infusion therapy: A retrospective analysis of a novel therapeutic approach to complex regional pain syndrome 5 (3):263–75. doi:10.1111/j.1526-4637.2004.04043.x.
  • D’Emilio, J. 2002. The world turned: essays on gay history, politics, and culture. Durham, NC: Duke University Press.
  • Dillon, P., J. Copeland, and K. Jansen. 2003. Patterns of use and harms associated with non- medical ketamine use. Drug and Alcohol Dependence 69 (1):23–28. doi:10.1016/S0376-8716(02)00243-0.
  • Domino, E. F., P. Chodoff, and G. Corssen. 1965. Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clinical Pharmacology and Therapeutics 6 (3):279–91. doi:10.1002/cpt196563279.
  • Dotson, J. W., D. L. Ackerman, and L. J. West. 1995. Ketamine abuse. Journal of Drug Issues 25 (4):751–57. doi:10.1177/002204269502500407.
  • Feltmann, K., T. H. Elgán, A. K. Strandberg, P. Kvillemo, N. Jayaram-Lindström, M. Grabski, and J. Gripenberg. 2021. Illicit drug use and associated problems in the nightlife scene: A potential setting for prevention. International Journal of Environmental Research and Public Health 18 (9):4789. doi:10.3390/ijerph18094789.
  • Frost, E. A. M. 2019. Ketamine: Newer uses emerge for an older drug. Topics in Pain Management 34 (6):1–7. doi:10.1097/01.TPM.0000550594.56362.6d.
  • Green, S. M., S. G. Rothrock, E. L. Lynch, M. Ho, T. Harris, R. Hestdalen, and K. Westcott. 1998. Intramuscular ketamine for pediatric sedation in the emergency department: Safety profile in 1,022 cases. Annals of Emergency Medicine 31 (6):688–97. doi:10.1016/S0196-0644(98)70226-4.
  • Heeringa, S. G., B. T. West, and P. A. Berglund. 2017. Applied survey data analysis. Boca Raton, FL: Chapman and Hall/CRC.
  • Jones, J. L., C. F. Mateus, R. J. Malcolm, K. T. Brady, and S. E. Back. 2018. Efficacy of ketamine in the treatment of substance use disorders: A systematic review. Frontiers in Psychiatry 9:277. doi:10.3389/fpsyt.2018.00277.
  • Kalsi, S. S., D. M. Wood, and P. I. Dargan. 2011. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerging Health Threats Journal 4 (1):7107. doi:10.3402/ehtj.v4i0.7107.
  • Klein, L. R., and J. B. Cole. 2021. Ketamine: Focusing on the facts and forgetting the fiction. Annals of Emergency Medicine 78 (1):132–39. doi:10.1016/j.annemergmed.2021.03.039.
  • Krauss, B., and S. M. Green. 2000. Sedation and analgesia for procedures in children. New England Journal of Medicine 342 (13):938–45. doi:10.1056/NEJM200003303421306.
  • Larkin, G. L., and A. L. Beautrais. 2011. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. International Journal of Neuropsychopharmacology 14 (8):1127–31. doi:10.1017/S1461145711000629.
  • Li, N., R.-J. Liu, J. M. Dwyer, M. Banasr, B. Lee, H. Son, X.-Y. Li, G. Aghajanian, and R. S. Duman. 2011. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biological Psychiatry 69 (8):754–61. doi:10.1016/j.biopsych.2010.12.015.
  • Lockwood, B. 2006. Ketamine: Dangerous Hallucinogen. New York: The Rosen Publishing Group, Inc.
  • Mayer, K. H., J. B. Bradford, H. J. Makadon, R. Stall, H. Goldhammer, and S. Landers. 2008. Sexual and gender minority health: What we know and what needs to be done. American Journal of Public Health 98 (6):989–95. doi:10.2105/AJPH.2007.127811.
  • McCambridge, J., A. Winstock, N. Hunt, and L. Mitcheson. 2007. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European Addiction Research 13 (1):57–64. doi:10.1159/000095816.
  • Ni, A., F. L. Cantrell, and R. F. Clark. 2018. Ketamine exposure demographics and outcomes over 16 years as reported to US poison centers. The American Journal of Emergency Medicine 36 (8):1459–62. doi:10.1016/j.ajem.2018.04.066.
  • Palamar, J. J., and K. M. Keyes. 2020b. Trends in drug use among electronic dance music party attendees in New York City, 2016–2019. Drug and Alcohol Dependence 209:107889. doi:10.1016/j.drugalcdep.2020.107889.
  • Palamar, J. J., C. Rutherford, and K. M. Keyes. 2021. Trends in ketamine use, exposures, and seizures in the United States. American Journal of Public Health, e1–e4.
  • Palamar, J. J., A. Salomone, C. Rutherford, and K. M. Keyes. 2020a. Extensive underreported exposure to ketamine among electronic dance music party attendees. Journal of General Internal Medicine 36 (1): 1–3.
  • Parsons, J. T., P. N. Halkitis, and D. S. Bimbi. 2006. Club drug use among young adults frequenting dance clubs and other social venues in New York City. Journal of Child & Adolescent Substance Abuse 15 (3):1–14. doi:10.1300/J029v15n03_01.
  • Riley, S. C., C. James, D. Gregory, H. Dingle, and M. Cadger. 2001. Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction 96 (7):1035–47. doi:10.1046/j.1360-0443.2001.967103513.x.
  • Roxburgh, A., T. Lea, J. de Wit, and L. Degenhardt. 2016. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. International Journal of Drug Policy 28:76–82. doi:10.1016/j.drugpo.2015.11.005.
  • Salloum, N. C., M. Fava, M. P. Freeman, M. Flynn, B. Hoeppner, R. S. Hock, C. Cusin, D. V. Iosifescu, M. H. Trivedi, and G. Sanacora. 2019. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depression and Anxiety 36 (3):235–43. doi:10.1002/da.22875.
  • Substance Abuse and Mental Health Services Administration. 2013. Drug abuse warning network, national estimates of drug-related emergency department visits. HHS publication no. (SMA) 13-4760, DAWN Series D −39. Rockville, MD: Substance Abuse and Mental Health Services Administration.
  • UK Government Home Office. (2018). Drug misuse: Findings from the 2017/2018 crime survey for England and wales. Accessed from https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment data/file/729249/drug-misuse-2018-hosb1418.pdf
  • Vidal Gine, C., F. Fernández Calderón, and J. Lopez Guerrero. 2016. Patterns of use, harm reduction strategies, and their relation to risk behavior and harm in recreational ketamine users. The American Journal of Drug and Alcohol Abuse 42 (3):358–69. doi:10.3109/00952990.2016.1141211.
  • White, P. F., W. L. Way, and A. J. Trevor. 1982. Ketamine—its pharmacology and therapeutic uses. The Journal of the American Society of Anesthesiologists 56 (2):119–36.
  • Wilkinson, S. T., M. Toprak, M. S. Turner, S. P. Levine, R. B. Katz, and G. Sanacora. 2017. A survey of the clinical, off-label use of ketamine as a treatment for psychiatric disorders. American Journal of Psychiatry 174 (7):695–96. doi:10.1176/appi.ajp.2017.17020239.
  • Winstock, A., (2020). On behalf of the GDS core research team.Global Drug Survey, Key Findings Report. https://www.globaldrugsurvey.com/wpcontent/uploads/2021/01/GDS2020-Executive-Summary.pdf
  • World Health Organization. (2016). Fact file on ketamine. Retrieved from https://www.who.int/medicines/news/20160309_FactFile_Ketamine.pdf.
  • Yockey, R. A., R. A. Vidourek, and K. A. King. 2020. Trends in LSD use among US adults: 2015- 2018. Drug and Alcohol Dependence 212:108071. doi:10.1016/j.drugalcdep.2020.108071.
  • Zinberg, N. E. 1984. Drug, set, and setting: the basis for controlled intoxicant use. 1st ed. New Haven, CT: Yale University Press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.